Beam Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.

About BEAM

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. 

CEO
John Evans
CEOJohn Evans
Employees
483
Employees483
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
483
Employees483

BEAM Key Statistics

Market cap
1.98B
Market cap1.98B
Price-Earnings ratio
-4.34
Price-Earnings ratio-4.34
Dividend yield
—
Dividend yield—
Average volume
2.58M
Average volume2.58M
High today
$20.81
High today$20.81
Low today
$19.56
Low today$19.56
Open price
$19.99
Open price$19.99
Volume
2.13M
Volume2.13M
52 Week high
$35.25
52 Week high$35.25
52 Week low
$13.53
52 Week low$13.53

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.